APLUF yields 16.67% · MRK yields 2.76%● Live data
📍 APLUF pulled ahead of the other in Year 1
Combined, APLUF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of APLUF + MRK for your $10,000?
Applus Services, S.A., together with its subsidiaries, provides testing, inspection, and certification services. It operates through four segments: Applus+ Energy & lndustry, Applus+ Laboratories, Applus+ Automotive, and Applus+ IDIADA. The Applus+ Energy & lndustry segment offers non-destructive testing, quality control, and accreditation services, as well as project management, supplier inspection, facility inspection, and asset certification and integrity services. This segment also provides qualified staff recruitment and hiring services for the oil and gas, aircraft, energy, mining, telecommunications, and construction industries. The Applus+ Laboratories segment offers a range of laboratory testing, system certification, and product development services across various industries and electronic payment systems, including aerospace and industrial sectors. The Applus+ Automotive segment provides mandatory vehicle roadworthiness testing services, as well as verifies vehicles' compliance with safety and emissions regulations in force in various countries. The Applus+ IDIADA segment offers design, engineering, testing, and certification services primarily to car manufacturers. It operates in Spain, rest of Europe, the United States, Canada, the Asia Pacific, the Middle East, Africa, and Latin America. The company was formerly known as Applus Technologies Holding, S.L. and changed its name to Applus Services, S.A. in March 2014. Applus Services, S.A. was founded in 1996 and is headquartered in Madrid, Spain.
Full APLUF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.